Insurance Coverage for NeuroStar TMS Therapy in Scottsdale, AZ
Understanding how to pay for mental health treatment is an important part of the decision-making process. At The Schulte Institute in Scottsdale, AZ, we are committed to making NeuroStar Advanced TMS Therapy and Spravato (esketamine) as accessible as possible by working directly with major insurance providers on your behalf. Below is a comprehensive overview of what to expect when it comes to insurance coverage for TMS therapy at our Scottsdale practice.
Request an AppointmentIs NeuroStar TMS Therapy Covered by Insurance?
If you have commercial medical insurance, there is a strong likelihood that your NeuroStar TMS Therapy sessions will be covered at The Schulte Institute — provided all qualifying criteria are met. This is determined through a prior authorization process with your insurance carrier before treatment begins. The growing coverage landscape for TMS reflects the high level of confidence that major payers have in this FDA-cleared, evidence-based treatment.
We are currently credentialed with the following insurance plans at our Scottsdale practice for NeuroStar TMS Therapy and Spravato:
Aetna, BlueCross BlueShield, Cigna, United Healthcare / Optum, and Tricare West Health Alliance.
Our administrative team handles benefit verification and works with you to gather the documentation insurers require before your first session, so there are no surprises when treatment begins. If you have questions about your specific plan, call (480) 941-9004 and our team will be happy to assist.
Coverage Requirements May Vary by Insurance Carrier
While many insurance companies cover NeuroStar TMS Therapy at our Scottsdale clinic, the specific requirements and coverage details can vary significantly from one plan to another. Most plans share certain baseline requirements before authorizing coverage. Understanding these requirements ahead of time helps set clear expectations and avoids delays in starting treatment.
Diagnosis documentation: Most insurance providers require a formal diagnosis of Major Depressive Disorder (MDD) or Obsessive-Compulsive Disorder (OCD) from a licensed medical provider. Some plans specify that the MDD must be moderate to severe. At your initial consultation, Dr. Schulte or Dr. Koreny will conduct a thorough psychiatric evaluation to document your diagnosis accurately.
Prior antidepressant trials: Because NeuroStar TMS is particularly effective for patients with treatment-resistant depression, most carriers require evidence that you have already tried at least two antidepressant medications at adequate doses and durations without achieving meaningful improvement. Our team will help you compile the necessary treatment history documentation for your insurer.
Additional requirements: Some plans may also require a documented trial of psychotherapy or augmentation strategies before approving TMS coverage. Our providers coordinate closely with your insurer to ensure all requirements are met efficiently and accurately. For more on the conditions TMS treats, visit our Conditions Treated page.
Understanding Your Out-of-Pocket Costs
Your out-of-pocket costs for NeuroStar TMS Therapy in Scottsdale will depend on several factors specific to your insurance plan, including your deductible, copay or coinsurance structure, and the number of sessions authorized. For some patients, treatment may be fully covered after meeting their deductible. For others, plans may cover a substantial portion of the cost but require a copay per session or a coinsurance percentage.
If you are on a high-deductible health plan and have not yet met your deductible for the year, you may be responsible for out-of-pocket costs until that threshold is reached — just as you would for any other medical procedure. We strongly encourage all patients to contact their insurance provider directly before scheduling treatment to confirm coverage, understand any cost-sharing requirements, and ask about prior authorization timelines. Our team at The Schulte Institute is here to support you through that process every step of the way. To explore other advanced treatment options we offer, visit our Spravato (esketamine) page or our NeuroStar Advanced TMS Therapy page.
Frequently Asked Questions About TMS Insurance Coverage in Scottsdale
Which insurance plans does The Schulte Institute accept for TMS therapy?
The Schulte Institute is credentialed with Aetna, BlueCross BlueShield, Cigna, United Healthcare / Optum, and Tricare West Health Alliance for NeuroStar TMS Therapy and Spravato. Coverage is subject to prior authorization and is not guaranteed. Our administrative team verifies your benefits before treatment begins so you have a clear understanding of your financial responsibility in advance. Call (480) 941-9004 with any questions about your specific plan.
What does prior authorization mean and how does the process work?
Prior authorization is a process in which your insurance company reviews your clinical history and diagnosis before approving coverage for a specific treatment. For TMS therapy, your insurer will typically require documentation of your MDD or OCD diagnosis, evidence of prior antidepressant trials, and in some cases records of psychotherapy attempts. Our team at The Schulte Institute manages the prior authorization process on your behalf, gathering the necessary records and submitting the required documentation to your insurance carrier before your first session.
What clinical criteria do I need to meet for insurance to cover TMS?
Most insurance carriers require a formal diagnosis of moderate to severe MDD or OCD, evidence of at least two failed antidepressant medication trials at adequate doses and durations, and in some cases a prior trial of psychotherapy. The exact criteria vary by carrier and plan. During your initial consultation at The Schulte Institute, our providers will document your diagnosis and treatment history in the format insurers require to support your prior authorization request.
Will insurance cover TMS if I have already tried many antidepressants?
Yes — in fact, having a documented history of multiple failed antidepressant trials often strengthens your case for coverage, since TMS is specifically indicated for treatment-resistant depression. The more detailed your medication history, the clearer the evidence of medical necessity becomes. Our team will help you compile and present your treatment history in the most effective way for your insurer’s prior authorization review.
Is Spravato (esketamine) also covered by insurance at The Schulte Institute?
Yes. The Schulte Institute accepts Aetna, BlueCross BlueShield, Cigna, Tricare, and UHC (Optum) for Spravato treatment as well. As with TMS, Spravato coverage is subject to prior authorization and is not guaranteed. Documentation of a qualifying TRD or MDD diagnosis and prior antidepressant treatment history will be required. Our team assists with the entire prior authorization process. Learn more on our Spravato page.
What if my insurance does not cover TMS or I am uninsured?
If your insurance does not cover TMS or you do not have insurance, please contact our office at (480) 941-9004 to discuss your options. Our team will do their best to help you explore alternative pathways to access treatment. We encourage all patients to verify coverage directly with their insurer and to ask our staff any questions about financial considerations before beginning the prior authorization process.
How long does the prior authorization process take before I can start TMS?
The prior authorization timeline varies by insurance carrier, but it typically takes between one and three weeks from submission of the required documentation to a coverage decision. Our team at The Schulte Institute works proactively to submit authorization requests as efficiently as possible and follows up with insurers on your behalf. Once authorization is approved, we schedule your initial mapping appointment and begin treatment as soon as your calendar allows.
